Healthcare Triangle Listed on Nasdaq; Industry Comparison Released
1 report, 1 independent
Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Healthcare Triangle is a publicly traded company on Nasdaq and received analyst ratings from MarketBeat on November 11, 2026. A report comparing Healthcare Triangle to its rivals in the Healthcare Technology industry noted that the company has a beta of 1.18, which is higher than the average beta of 1.11 for its rivals.
From tickerreport.com
Why it matters
The comparison showed that while rivals have higher top-line revenue, Healthcare Triangle has lower earnings per share and is trading at a lower price-to-earnings ratio. Institutional ownership of Healthcare Triangle shares is 0.3%, compared to 42.4% for all companies in the industry.
From tickerreport.com
Who's involved
- NasdaqProvides the stock exchange infrastructure for Healthcare Triangle.
- MarketBeatProvides analyst ratings and financial tracking for Healthcare Triangle.
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
MarketBeat
American personal finance blog
Related events
- MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.
- MarketBeat provided analyst ratings for MarketAxess, a company listed on the Nasdaq exchange.
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.
- MarketBeat reported analyst ratings for C.H. Robinson Worldwide, a company listed on the Nasdaq exchange.
- MarketBeat reported analyst ratings for Sarepta Therapeutics and Emergent BioSolutions, both of which are listed on Nasdaq.